TuHURA Biosciences, Inc. Share Price
NASDAQ: HURA | Micro CapTuHURA Biosciences, Inc. Stock Performance
Open $2.09 | Prev. Close $2.10 | Circuit Range N/A |
Day Range $2.09 - $2.13 | Year Range $0.42 - $3.89 | Volume 3,487 |
Average Traded $2.11 |
TuHURA Biosciences, Inc. Share Price Today
As of 10 August 2026, TuHURA Biosciences, Inc.'s share price is $2.12. The stock opened at $2.09, compared to its previous close of $2.10. During today's trading session, TuHURA Biosciences, Inc.'s share price traded between $2.09 and $2.13, with an average price of $2.11. Over the past 52 weeks, the stock has recorded a high of $3.89 and a low of $0.42. In terms of performance, TuHURA Biosciences, Inc.'s share price has risen by 27.33% over the last six months and is down 21.48% on a year-on-year basis.
TuHURA Biosciences, Inc. Share Price Chart
TuHURA Biosciences, Inc. Stock Fundamentals & Key Indicators
Market Cap $101.61M | PE Ratio (TTM) -3.37 | Dividend Yield N/A |
EPS (TTM) $-0.63 | Revenue (TTM) N/A | Return On Equity (TTM) -143.57% |
Profit Margin N/A | Debt to Equity 0.31 | Quarterly Earnings Growth YoY -228.67% |
TuHURA Biosciences, Inc. Quarterly Profit & Loss
All figures in USD
TuHURA Biosciences, Inc. Annual Profit & Loss
All figures in USD
About TuHURA Biosciences, Inc.
TuHURA Biosciences, Inc., a clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies. The company's lead product candidate includes IFx2.0, an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors. It is also preparing to initiate a single randomized placebo-controlled which is in Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda; and Delta receptor technology to develop tumor microenvironment modulators in the form of first-in-class bi-specific antibody-peptide conjugates and antibody-drug conjugates targeting Myeloid Derived Suppressor Cells. In addition, the company is also developing Immune Fx; IFx-3.0, an mRNA innate immune agonist candidate for intravenous or autologous whole cell administration for blood-related cancers. The company was formerly known as Morphogenesis, Inc. and changed its name to TuHURA Biosciences, Inc. in December 2023. The company was founded in 1995 and is based in Tampa, Florida. TuHURA Biosciences, Inc. operates as a subsidiary of CohBar, Inc.
TuHURA Biosciences, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $2.22 | $2.12 | -2.08% |
Jul 2026 | $2.38 | $2.17 | -7.68% |
Jun 2026 | $2.23 | $2.35 | +2.85% |
May 2026 | $2.23 | $2.28 | +1.33% |
Apr 2026 | $1.81 | $2.25 | +26.76% |
Mar 2026 | $1.62 | $1.77 | +6.61% |
Feb 2026 | $0.57 | $1.67 | +208.91% |
Jan 2026 | $0.75 | $0.54 | -27.94% |
Dec 2025 | $1.96 | $0.75 | -62.69% |
Nov 2025 | $2.47 | $2.00 | -21.68% |
Oct 2025 | $2.49 | $2.56 | +3.23% |
Sep 2025 | $2.68 | $2.48 | -8.15% |
HURA Share Price FAQs
What is TuHURA Biosciences, Inc. share price today?
What is the 52 week high and 52 week low of TuHURA Biosciences, Inc. stock?
What is HURA's market capitalisation today?
What is HURA's net income for the last quarter?
What is the 5 year returns of HURA?
What is the high & low stock price of HURA today?
Can I buy HURA shares in India?